Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Adagene Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 27 | 16 | −11 |
| Shares | 6.44M | 5.94M | −497.3K (−7.7%) |
| Value | $115.5M | $80.5M | −$35.0M (−30.3%) |
New holders (1)
Institutions that held Adagene Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 21,953 | $298.0K | 0.00% |
Sold out (12)
Institutions that held Adagene Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Credit Suisse AG | 605,638 | $10.9M |
| Allianz Asset Management GmbH | 438,500 | $7.87M |
| Caas Capital Management LP | 69,000 | $1.24M |
| Citigroup Inc | 63,536 | $1.14M |
| HSBC Holdings PLC | 48,702 | $885.0K |
| Marshall Wace North America L.P. | 35,903 | $644.0K |
| JPMorgan Chase & Co | 34,360 | $617.0K |
| Citadel Advisors LLC | 22,371 | $402.0K |
| Two Sigma Investments, LP | 20,232 | $363.0K |
| Pinz Capital Management, LP | 16,667 | $299.0K |
| Norges Bank | 12,000 | $215.0K |
| Legal & General Group Plc | 3,000 | $54.0K |